Clinical trialPhase 1Completed
Epidural Analgesia Use in Pancreatic Resections
- Outcome
- Finished, no results posted
- Phase
- Phase 1
- Status
- Completed
- Study type
- Interventional
- Start
- 7 June 2016
- Ended
- 7 February 2020
- Enrollment
- 23 participants
- Sites
- 1
- Primary outcomes
- Total consumption of morphine or morphine-equivalent in patients undergoing pancreatic resections in the control group compared with the study group
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 12 March 2020
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The rationale for this study is to investigate the benefits of epidural analgesia in pancreatic resections in a prospective, single blind, randomized control trial. This study will evaluate both short and long-term outcomes related to epidural analgesia, providing a longitudinal and comprehensive perspective to the advantages and disadvantages of this technique. The investigators hypothesize that the use of epidural analgesia reduces a patient's consumption of morphine or morphine-equivalent in the post-operative period following pancreatic resections.